Probiotics expert Probi has announced that it will be attending this year's SupplySide West, where the company will be debuting a new weight management probiotic.
Metabolic Health by Probi, the company's latest probiotic strain is designed to support a user's metabolism, while also supporting their heart health.
The product combines two probiotic strains, Lactiplantibacillus plantarum 299v (LP299V®) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2®).
According to Probi, the strain is also backed by robust clinical evidence, and can offer flexibility for consumers.
Laying out the facts
LP299V has more than 230 publications and 8 clinical trials exploring its functionality in metabolic support.
The probiotic strain can positively benefit cardiovascular health by moderating cholesterol levels, while also diminishing the impact of inflammation and allowing for blood vessel dilation.
L. Paracasei 8700:2, on the other hand, is supported by more than 30 publications, which highlight the strain's potential in decreasing key risk factors associated with metabolic syndrome.
Recent clinical trials have demonstrated the probiotic's ability to lower blood pressure and cholesterol levels, while also assisting a consumer in managing their weight.
Currently, 1.9 billion adults are considered overweight worldwide,1 and 88% of US adults are deemed as metabolically unhealthy.2
Therefore, the need for solutions that assist individuals in supporting the healthy functioning of their metabolism have become crucial.
Probi's CEO, Anita Johansen, commented: “Our aim is to help people take control of their microbiome, their gut, and live better for longer."
"With this product, we want to specifically support metabolic well-being. With cardiovascular disease and type 2 diabetes being the top two causes of death globally, the need couldn’t be more urgent,”
